class="wp-theme-Newspaper supp-body td-standard-pack global-block-template-1 tdc-header-template tdc-footer-template td-animation-stack-type0 td-full-layout"
IARC Group 2B carcinogen (possibly carcinogenic to humans) via N-nitroso formation. FDA public health advisory against cosmetic products containing DEA. Avoid in oral supplements entirely. Prohibited in EU cosmetics as a precautionary measure. No acceptable intake for mutagenic carcinogens.
Ethanolamine compound used as pH adjuster and emulsifier in cosmetics and some pharmaceutical excipients. Reacts with nitrosating agents to form N-nitrosodiethanolamine (NDELA) — a potent carcinogen. FDA has warned against use of DEA-containing products. IARC Group 2B carcinogen.
Acts on cellular signalling pathways relevant to the documented clinical indications. Contains bioactive compounds with enzyme-modulating, receptor-binding, or antioxidant properties studied in peer-reviewed literature.
| Population | Safety rating | Max safe dose |
|---|---|---|
| General | Likely unsafe | — |
| Pregnancy | Likely unsafe | — |
| Elderly | Likely unsafe | — |
No peer-reviewed clinical trial data found for this ingredient.
Data by supplement.ge — Public Health Institute of Georgia (PHIG)